FDA OKs Phase 2 Study of Antria’s Stem Cell Technology in Plastic Surgery
Antria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
Antria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
Dr Rami Batniji discusses how Evolysse’s cold technology manufacturing process may offer clinical advantages over traditional hyaluronic acid fillers.